Cargando…
QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
Malaria is a disease caused by protozoan parasites of the genus Plasmodium that affects millions of people worldwide. In recent years there have been parasite resistances to several drugs, including the first-line antimalarial treatment. With the aim of proposing new drugs candidates for the treatme...
Autores principales: | Santos-Garcia, Letícia, de Mecenas Filho, Marco Antônio, Musilek, Kamil, Kuca, Kamil, Ramalho, Teodorico Castro, da Cunha, Elaine Fontes Ferreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225221/ https://www.ncbi.nlm.nih.gov/pubmed/30217086 http://dx.doi.org/10.3390/molecules23092348 |
Ejemplares similares
-
Theoretical Studies Aimed at Finding FLT3 Inhibitors and a Promising Compound and Molecular Pattern with Dual Aurora B/FLT3 Activity
por: Fernandes, Ítalo Antônio, et al.
Publicado: (2020) -
Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors
por: Schlott, Anja C., et al.
Publicado: (2019) -
Can Inhibitors of Snake Venom Phospholipases A(2) Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study
por: Sales, Thaís A., et al.
Publicado: (2017) -
QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human N-Myristoyltransferase (Hs-NMT) Inhibitors
por: Zaki, Magdi E. A., et al.
Publicado: (2021) -
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019)